Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	394,813	463,131	503,841	650,295	704,427	985,637
Market Cap Growth	-6.03%	-8.08%	-22.52%	-7.69%	-28.53%	36.03%
Enterprise Value	325,888	412,429	409,238	545,580	602,944	888,822
Last Close Price	5311.00	6179.59	6620.05	8681.80	8603.18	11894.49
PE Ratio	33.46	46.01	24.77	32.48	35.73	51.32
Forward PE	31.26	30.11	24.52	33.46	34.40	48.90
PS Ratio	2.44	2.80	2.91	3.91	4.54	6.55
PB Ratio	1.90	2.17	2.46	3.29	3.60	5.40
P/TBV Ratio	2.07	2.40	2.75	3.52	3.85	5.81
P/FCF Ratio	39.43	-	89.91	37.88	37.56	48.82
P/OCF Ratio	19.81	41.18	27.44	20.38	31.42	41.09
PEG Ratio	-	-	20.43	13.39	7.89	7.89
EV/Sales Ratio	2.02	2.49	2.36	3.28	3.88	5.91
EV/EBITDA Ratio	10.70	12.60	12.92	17.12	19.59	29.71
EV/EBIT Ratio	14.83	16.69	15.97	20.58	23.23	34.44
EV/FCF Ratio	32.55	-	73.03	31.78	32.15	44.02
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.03	0.03	0.02	0.02	0.02
Debt / FCF Ratio	0.08	-	0.18	0.05	0.03	0.03
Asset Turnover	0.62	0.62	0.66	0.65	0.63	0.64
Inventory Turnover	2.55	3.37	3.88	4.51	4.55	4.47
Quick Ratio	2.21	2.48	2.37	2.94	3.24	2.94
Current Ratio	2.92	3.11	2.82	3.34	3.59	3.28
Return on Equity (ROE)	5.65%	4.81%	10.10%	10.18%	10.43%	10.81%
Return on Assets (ROA)	5.25%	5.80%	6.12%	6.52%	6.61%	6.84%
Return on Capital (ROIC)	6.54%	7.35%	7.92%	8.39%	8.55%	9.04%
Return on Capital Employed (ROCE)	10.30%	11.30%	12.10%	13.00%	12.90%	13.70%
Earnings Yield	2.99%	2.17%	4.04%	3.08%	2.80%	1.95%
FCF Yield	2.54%	-3.20%	1.11%	2.64%	2.66%	2.05%
Dividend Yield	1.96%	1.65%	1.53%	1.04%	0.97%	0.65%
Payout Ratio	64.22%	74.55%	35.52%	32.51%	31.71%	30.12%
Buyback Yield / Dilution	0.83%	1.98%	1.67%	1.27%	0.05%	0.32%
Total Shareholder Return	2.81%	3.63%	3.20%	2.31%	1.01%	0.97%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.